Skip to content
Disclosery

Alphabet Inc.

Follow

13F filer, CIK 1652044, Mountain View, CA

Alphabet Inc. reported $2,408,574,709 across 37 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-07. Its ten largest share positions make up 89.13% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001652044-25-000096

Period
2025-09-30
Reported value
$2.41B
Holdings
37
Top 10 weight
89.13%
New
2
Sold out
1

Part of the filer group Alphabet Inc.

How groups are built

Stakes and trades reported after 2025-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • WULF TERAWULF INC: 13G 41,011,803 shares, 7.6% of the class, 13G filed 2026-09-25, 0001193125-26-402852Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
BBOTnew+2,823,126$32.7M
FIGnew+215,582$11.2M
PRMEadded+1,500,000$8.31M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VERVE THERAPEUTICS INCexited-12,168,489-$137M
MTSRreduced-1,178,216-$61.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001652044-25-000096, largest first. % of portfolio is the value over $2,408,574,709, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ASTSAST SPACEMOBILE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 8,943,486 shares; 2025Q2: 8,943,486 shares; 2025Q3: 8,943,486 shares 8,943,486$439M18.22%0Timeline
PLPLANET LABS PBCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 31,942,641 shares; 2024Q4: 31,942,641 shares; 2025Q1: 31,942,641 shares; 2025Q2: 31,942,641 shares; 2025Q3: 31,942,641 shares 31,942,641$415M17.21%0Timeline
ARMARM HOLDINGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,960,784 shares; 2024Q4: 1,960,784 shares; 2025Q1: 1,960,784 shares; 2025Q2: 1,960,784 shares; 2025Q3: 1,960,784 shares 1,960,784$277M11.52%0Timeline
MTSRMETSERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 4,961,744 shares; 2025Q2: 4,961,744 shares; 2025Q3: 3,783,528 shares 3,783,528$198M8.22%-1,178,216Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,256,175 shares; 2024Q4: 4,133,277 shares; 2025Q1: 4,133,277 shares; 2025Q2: 4,133,277 shares; 2025Q3: 4,133,277 shares 4,133,277$193M8.01%0Timeline
FRSHFRESHWORKS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 16,206,643 shares; 2024Q4: 16,206,643 shares; 2025Q1: 16,206,643 shares; 2025Q2: 16,206,643 shares; 2025Q3: 16,206,643 shares 16,206,643$191M7.92%0Timeline
TEMTEMPUS AI INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,551,102 shares; 2024Q4: 1,551,102 shares; 2025Q1: 1,551,102 shares; 2025Q2: 1,551,102 shares; 2025Q3: 1,551,102 shares 1,551,102$125M5.2%0Timeline
GTLBGITLAB INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 9,758,333 shares; 2024Q4: 6,091,238 shares; 2025Q1: 2,724,712 shares; 2025Q2: 2,724,712 shares; 2025Q3: 2,724,712 shares 2,724,712$123M5.1%0Timeline
PATHUIPATH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,034,337 shares; 2024Q4: 7,034,337 shares; 2025Q1: 7,034,337 shares; 2025Q2: 7,034,337 shares; 2025Q3: 7,034,337 shares 7,034,337$94.1M3.91%0Timeline
PRMEPRIME MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 15,062,498 shares; 2024Q4: 15,062,498 shares; 2025Q1: 15,062,498 shares; 2025Q2: 15,062,498 shares; 2025Q3: 16,562,498 shares 16,562,498$91.8M3.81%+1,500,000Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,036,937 shares; 2024Q4: 1,036,937 shares; 2025Q1: 1,036,937 shares; 2025Q2: 1,036,937 shares; 2025Q3: 1,036,937 shares 1,036,937$69.8M2.9%0Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,412,471 shares; 2025Q2: 2,412,471 shares; 2025Q3: 2,412,471 shares 2,412,471$62.6M2.6%0Timeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,823,126 shares 2,823,126$32.7M1.36%newTimeline
FIGFIGMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 215,582 shares 215,582$11.2M0.46%newTimeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,464,015 shares; 2024Q4: 1,464,015 shares; 2025Q1: 1,464,015 shares; 2025Q2: 1,464,015 shares; 2025Q3: 1,464,015 shares 1,464,015$10.8M0.45%0Timeline
SANASANA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,812,500 shares; 2024Q4: 2,812,500 shares; 2025Q1: 2,812,500 shares; 2025Q2: 2,812,500 shares; 2025Q3: 2,812,500 shares 2,812,500$9.98M0.41%0Timeline
OSCROSCAR HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 481,988 shares; 2024Q4: 481,988 shares; 2025Q1: 481,988 shares; 2025Q2: 481,988 shares; 2025Q3: 481,988 shares 481,988$9.12M0.38%0Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 208,697 shares; 2024Q4: 208,697 shares; 2025Q1: 208,697 shares; 2025Q2: 208,697 shares; 2025Q3: 208,697 shares 208,697$8.21M0.34%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,568,753 shares; 2024Q4: 1,568,753 shares; 2025Q1: 1,568,753 shares; 2025Q2: 1,568,753 shares; 2025Q3: 1,568,753 shares 1,568,753$8.19M0.34%0Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 321,604 shares; 2024Q4: 321,604 shares; 2025Q1: 321,604 shares; 2025Q2: 321,604 shares; 2025Q3: 321,604 shares 321,604$7.81M0.32%0Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 241,264 shares; 2024Q4: 241,264 shares; 2025Q1: 241,264 shares; 2025Q2: 241,264 shares; 2025Q3: 241,264 shares 241,264$7.01M0.29%0Timeline
LYELLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 293,256 shares; 2025Q3: 293,256 shares 293,256$4.76M0.2%0Timeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 500,901 shares; 2024Q4: 500,901 shares; 2025Q1: 500,901 shares; 2025Q2: 500,901 shares; 2025Q3: 500,901 shares 500,901$2.45M0.1%0Timeline
WGSGENEDX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 22,711 shares; 2024Q4: 22,711 shares; 2025Q1: 22,711 shares; 2025Q2: 22,711 shares; 2025Q3: 22,711 shares 22,711$2.45M0.1%0Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 640,882 shares; 2024Q4: 640,882 shares; 2025Q1: 640,882 shares; 2025Q2: 640,882 shares; 2025Q3: 640,882 shares 640,882$2.1M0.09%0Timeline
TCRXTSCAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,077,080 shares; 2024Q4: 1,077,080 shares; 2025Q1: 1,077,080 shares; 2025Q2: 1,077,080 shares; 2025Q3: 1,077,080 shares 1,077,080$1.96M0.08%0Timeline
BRNSBARINTHUS BIOTHERAPEUTICS PLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,513,644 shares; 2024Q4: 1,513,644 shares; 2025Q1: 1,513,644 shares; 2025Q2: 1,513,644 shares; 2025Q3: 1,513,644 shares 1,513,644$1.89M0.08%0Timeline
SPROSPERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 889,979 shares; 2024Q4: 889,979 shares; 2025Q1: 889,979 shares; 2025Q2: 889,979 shares; 2025Q3: 889,979 shares 889,979$1.67M0.07%0Timeline
TNYATENAYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 915,705 shares; 2024Q4: 915,705 shares; 2025Q1: 915,705 shares; 2025Q2: 915,705 shares; 2025Q3: 915,705 shares 915,705$1.48M0.06%0Timeline
HYPRHYPERFINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 898,720 shares; 2024Q4: 898,720 shares; 2025Q1: 898,720 shares; 2025Q2: 898,720 shares; 2025Q3: 898,720 shares 898,720$1.3M0.05%0Timeline
EXASEXACT SCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 23,205 shares; 2024Q4: 23,205 shares; 2025Q1: 23,205 shares; 2025Q2: 23,205 shares; 2025Q3: 23,205 shares 23,205$1.27M0.05%0Timeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 698,262 shares; 2024Q4: 698,262 shares; 2025Q1: 698,262 shares; 2025Q2: 698,262 shares; 2025Q3: 698,262 shares 698,262$1.14M0.05%0Timeline
GUTSFRACTYL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 662,584 shares; 2024Q4: 662,584 shares; 2025Q1: 662,584 shares; 2025Q2: 662,584 shares; 2025Q3: 662,584 shares 662,584$1.05M0.04%0Timeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 175,866 shares; 2024Q4: 175,866 shares; 2025Q1: 175,866 shares; 2025Q2: 175,866 shares; 2025Q3: 175,866 shares 175,866$521K0.02%0Timeline
QNCXQUINCE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 189,122 shares; 2024Q4: 189,122 shares; 2025Q1: 189,122 shares; 2025Q2: 189,122 shares; 2025Q3: 189,122 shares 189,122$308K0.01%0Timeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 14,262 shares; 2024Q4: 14,262 shares; 2025Q1: 14,262 shares; 2025Q2: 14,262 shares; 2025Q3: 14,262 shares 14,262$131K0.01%0Timeline
RGENREPLIGEN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 383 shares; 2024Q4: 383 shares; 2025Q1: 383 shares; 2025Q2: 383 shares; 2025Q3: 383 shares 383$51.2K<0.01%0Timeline

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
VERVE THERAPEUTICS INCVERVE THERAPEUTICS INC12,168,489$137Mshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001652044-25-000096 base2025-11-07acceptance time not in the bulk data set